Bulletin
Investor Alert

New York Markets Open in:

SQZ Biotechnologies Co.

NYS: SQZ

GO
/marketstate/country/us

Before the Bell

 --Quotes are delayed by 20 min

May 27, 2022, 8:00 a.m.

SQZ
/zigman2/quotes/222210446/composite

$

3.45

Change

0.00 0.00%

Volume

Volume 2

Quotes are delayed by 20 min

/zigman2/quotes/222210446/composite

Previous close

$ 3.45

$ 3.45

Change

+0.10 +2.99%

Day low

Day high

$3.31

$3.58

Open

52 week low

52 week high

$2.73

$16.17

Open

Klavis F. Jensen

Founder of i2chem, Inc. and SQZ Biotechnologies Co., Klavis F. Jensen is on the board of SQZ Biotechnologies Co. and Professor at Massachusetts Institute of Technology.

In the past Dr. Jensen held the position of Director at Technical University of Denmark.

Dr. Jensen received an undergraduate degree from the University of Wisconsin and a graduate degree from Technical University of Denmark.

Transactions

Date Shares Transaction Value
11/03/2020 14,662   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Ms. Amy L. Schulman
Chairman
Dr. Armon Sharei
President, CEO, CFO & Director
Dr. Howard Bernstein
Chief Scientific Officer
Mr. Micah Zajic
Chief Business Officer
Dr. Jonathan Gilbert
Vice President-Exploratory
Dr. Ricardo Zwirtes
Vice President-Clinical Development
Ms. Kyle Feldman
Talent Partner
Mr. Richard Capasso
Chief Accounting Officer
Mr. Michael Kaiser
Investor Relations Contact
Mr. David First
Chief People Officer
Mr. Lawrence J. Knopf
General Counsel
Mr. Andrew Elnatan
Vice President-Regulatory Affairs
Dr. Paul B. Bolno
Independent Director
Dr. Sapna R. Srivastava
Independent Director
Dr. Marc Schegerin
Independent Director
Dr. Bernard Coulie
Independent Director
Dr. Patrick Volkert Vink
Independent Director
Dr. Klavis F. Jensen
Independent Director
Mr. Marc W. Elia
Independent Director
Dr. Pushkal P. Garg
Independent Director
Link to MarketWatch's Slice.